Medicaments based on metronidazole or on a synergic mixture of metronidazole and clindamycin
AssigneeCentre International de Recherches Dermatologiques Galderma (Cird Galderma)
InventorsJanusz Czernielewski, Josiane Allec, Martine Bouclier
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of metronidazole, or preferably of a combination of metronidazole and clindamycin, as active principle for the manufacture of pharmaceutical compositions, more particularly dermatological compositions, intended for an anti-inflammatory treatment by the topical route.
Claims14
A method for the treatment of inflammation, said method comprising administering a composition which comprises an effective amount of metronidazole and clindamycin and a pharmaceutically acceptable carrier therefor.
A method for the treatment of inflammation, said method comprising topically administering a pharmaceutical composition comprising an anti-inflammatory effective amount of metronidazole and a topical pharmaceutically acceptable carrier therefor.
Dependencies are inferred from the claim text.